Blau Farmacêutica Statistics
Total Valuation
BVMF:BLAU3 has a market cap or net worth of BRL 2.13 billion. The enterprise value is 2.23 billion.
Market Cap | 2.13B |
Enterprise Value | 2.23B |
Important Dates
The next estimated earnings date is Wednesday, March 19, 2025.
Earnings Date | Mar 19, 2025 |
Ex-Dividend Date | Sep 27, 2024 |
Share Statistics
BVMF:BLAU3 has 177.68 million shares outstanding. The number of shares has decreased by -0.08% in one year.
Current Share Class | n/a |
Shares Outstanding | 177.68M |
Shares Change (YoY) | -0.08% |
Shares Change (QoQ) | +156.12% |
Owned by Insiders (%) | 83.30% |
Owned by Institutions (%) | 6.01% |
Float | 29.68M |
Valuation Ratios
The trailing PE ratio is 11.36 and the forward PE ratio is 7.48. BVMF:BLAU3's PEG ratio is 0.83.
PE Ratio | 11.36 |
Forward PE | 7.48 |
PS Ratio | 1.26 |
PB Ratio | 1.01 |
P/TBV Ratio | 1.12 |
P/FCF Ratio | 9.92 |
P/OCF Ratio | n/a |
PEG Ratio | 0.83 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.24, with an EV/FCF ratio of 10.41.
EV / Earnings | 11.92 |
EV / Sales | 1.32 |
EV / EBITDA | 7.24 |
EV / EBIT | 8.39 |
EV / FCF | 10.41 |
Financial Position
The company has a current ratio of 3.48, with a Debt / Equity ratio of 0.26.
Current Ratio | 3.48 |
Quick Ratio | 2.27 |
Debt / Equity | 0.26 |
Debt / EBITDA | 1.78 |
Debt / FCF | 2.57 |
Interest Coverage | 4.13 |
Financial Efficiency
Return on equity (ROE) is 9.05% and return on invested capital (ROIC) is 6.38%.
Return on Equity (ROE) | 9.05% |
Return on Assets (ROA) | 5.26% |
Return on Invested Capital (ROIC) | 6.38% |
Return on Capital Employed (ROCE) | 9.54% |
Revenue Per Employee | 887,276 |
Profits Per Employee | 98,445 |
Employee Count | 1,900 |
Asset Turnover | 0.53 |
Inventory Turnover | 1.82 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.07% in the last 52 weeks. The beta is 0.36, so BVMF:BLAU3's price volatility has been lower than the market average.
Beta (5Y) | 0.36 |
52-Week Price Change | +7.07% |
50-Day Moving Average | 12.75 |
200-Day Moving Average | 12.52 |
Relative Strength Index (RSI) | 44.07 |
Average Volume (20 Days) | 163,615 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BVMF:BLAU3 had revenue of BRL 1.69 billion and earned 187.05 million in profits. Earnings per share was 1.05.
Revenue | 1.69B |
Gross Profit | 596.47M |
Operating Income | 265.88M |
Pretax Income | 238.24M |
Net Income | 187.05M |
EBITDA | 302.15M |
EBIT | 265.88M |
Earnings Per Share (EPS) | 1.05 |
Balance Sheet
The company has 431.95 million in cash and 549.51 million in debt, giving a net cash position of -117.57 million or -0.66 per share.
Cash & Cash Equivalents | 431.95M |
Total Debt | 549.51M |
Net Cash | -117.57M |
Net Cash Per Share | -0.66 |
Equity (Book Value) | 2.08B |
Book Value Per Share | 11.80 |
Working Capital | 1.13B |
Cash Flow
In the last 12 months, operating cash flow was 332.65 million and capital expenditures -118.48 million, giving a free cash flow of 214.17 million.
Operating Cash Flow | 332.65M |
Capital Expenditures | -118.48M |
Free Cash Flow | 214.17M |
FCF Per Share | 1.21 |
Margins
Gross margin is 35.38%, with operating and profit margins of 15.77% and 11.10%.
Gross Margin | 35.38% |
Operating Margin | 15.77% |
Pretax Margin | 14.13% |
Profit Margin | 11.10% |
EBITDA Margin | 17.92% |
EBIT Margin | 15.77% |
FCF Margin | 12.70% |
Dividends & Yields
BVMF:BLAU3 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 36.38% |
Buyback Yield | 0.08% |
Shareholder Yield | 0.08% |
Earnings Yield | 8.80% |
FCF Yield | 10.08% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BVMF:BLAU3 has an Altman Z-Score of 2.77. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.77 |
Piotroski F-Score | n/a |